Physician profile
Robert G Fernandez
NPI 1790743151
$520.73
in general payments reported to CMS, 2019-2025
8 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.90 · 2023: $119 · 2024: $109 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $128.78 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $125.13 | 2024-2025 | Freestyle Libre 3 |
| Abbvie INC. | $89.31 | 2023-2024 | |
| Lilly USA, LLC | $55.28 | 2024-2025 | Mounjaro, Jardiance, Zepbound |
| Kyowa Kirin, INC. | $51.25 | 2024-2025 | Crysvita |
| Mannkind Corporation | $32.76 | 2023 | Afrezza |
| Glaxosmithkline, LLC. | $23.32 | 2025 | Bexsero, Pediarix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.